Howie Latimer

Howie Latimer has a strong background in scientific research and development within the biotechnology sector. Currently serving as the Manager of Cell Based Assays and previously as Principal Associate Scientist at Kelonia Therapeutics since April 2021, Howie has extensive experience from prior roles at bluebird bio, where positions ranged from Associate Scientist II to Senior Associate Scientist II between March 2014 and April 2021. Additional experience includes a Research Associate role at EpiVax, Inc., and a Research Technician position at Massachusetts General Hospital, where Howie examined the effects of oncolytic virus on human brain tumor cells. Earlier in the career, Howie worked as a Research Associate at Merrimack Pharmaceuticals and as a Microbiology Technician at Altran Solutions. Howie holds a Bachelor's degree in Biology from Northeastern University, earned between 2004 and 2009.